A study of the clinical safety, tolerability, and efficacy of zoledronic acid compared to an oral bisphosphonate
Phase of Trial: Phase III
Latest Information Update: 26 Apr 2012
At a glance
- Drugs Bisphosphonates; Zoledronic acid
- Indications Postmenopausal osteoporosis
- Focus Registrational; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 26 Apr 2012 Actual end date Jun 2005 added as reported by ClinicalTrials.gov.
- 04 Oct 2005 New trial record.